Skip to main content
Premium Trial:

Request an Annual Quote

Integrated DNA Technologies, 3CR Bioscience to Offer Custom Genotyping Screening Assays

NEW YORK – Integrated DNA Technologies (IDT) said today that it has partnered with UK firm 3CR Bioscience to offer customized assays for genotypic screening applications, which the firms believe will speed up and curb costs of high-volume genotyping.

As part of the collaboration, the team is integrating IDT's oligo synthesis technology with 3CR's PCR Allele Competitive Extension (PACE) Genotyping Master Mix and expertise in designing allele-specific assays. 

According to IDT, a unit of Danaher, researchers will be able to work with an integrated technical service team to design and order custom PACE SNP assays. The firms believe the new service will lower the cost per sample compared to existing assays on the market. 

"Our joint efforts provide a system that combines the superior performance of the 3CR master mix with high-quality oligonucleotides from IDT," Ben Viering, IDT VP of business development, said in a statement. "The combination provides a genotyping solution that is robust, highly sensitive, and economical." 

Financial details of the agreement were not disclosed. 

The firms expect agricultural biologists to benefit from the collaboration, as it sees the new service ideal for high-volume genotyping screening required for plant breeding experiments. 

"Our high-performance PACE master mix, based on a proprietary polymerase technology, pairs well with IDT's industry-leading quality oligo synthesis to provide a reliable genotyping solution," Steve Asquith, 3CR's managing director, said in a statement.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.